CRL logo

CRL Net Income

Annual Net Income

$22.20 M
-$452.42 M-95.32%

December 28, 2024


Summary


Performance

CRL Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRLprofitabilitymetrics:

Quarterly Net Income

-$213.41 M
-$282.69 M-408.05%

December 28, 2024


Summary


Performance

CRL Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRLprofitabilitymetrics:

TTM Net Income

$22.20 M
-$400.50 M-94.75%

December 28, 2024


Summary


Performance

CRL TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCRLprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

CRL Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-95.3%-327.6%-95.0%
3 y3 years-94.3%-327.6%-95.0%
5 y5 years-91.2%-327.6%-95.0%

CRL Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-95.4%at low-213.9%at low-95.5%at low
5 y5-year-95.4%at low-213.9%at low-95.5%at low
alltimeall time-95.4%+104.3%-213.9%+67.7%-95.5%+103.9%

Charles River Laboratories International Net Income History

DateAnnualQuarterlyTTM
Dec 2024
$22.20 M(-95.3%)
-$213.41 M(-408.1%)
$22.20 M(-94.7%)
Sep 2024
-
$69.28 M(-26.1%)
$422.70 M(-4.1%)
Jun 2024
-
$93.78 M(+29.2%)
$440.81 M(-0.7%)
Mar 2024
-
$72.56 M(-61.2%)
$444.05 M(-6.4%)
Dec 2023
$474.62 M(-2.4%)
$187.08 M(+114.1%)
$474.62 M(-0.1%)
Sep 2023
-
$87.39 M(-9.9%)
$474.95 M(-1.9%)
Jun 2023
-
$97.02 M(-5.9%)
$484.03 M(-2.5%)
Mar 2023
-
$103.13 M(-45.0%)
$496.33 M(+2.1%)
Dec 2022
$486.23 M(+24.4%)
$187.41 M(+94.3%)
$486.23 M(+11.4%)
Sep 2022
-
$96.47 M(-11.8%)
$436.39 M(-1.6%)
Jun 2022
-
$109.32 M(+17.5%)
$443.35 M(+4.9%)
Mar 2022
-
$93.02 M(-32.4%)
$422.47 M(+8.1%)
Dec 2021
$390.98 M(+7.3%)
$137.58 M(+33.0%)
$390.98 M(-1.4%)
Sep 2021
-
$103.43 M(+16.9%)
$396.60 M(+0.1%)
Jun 2021
-
$88.45 M(+43.7%)
$396.08 M(+5.6%)
Mar 2021
-
$61.53 M(-57.0%)
$375.06 M(+3.0%)
Dec 2020
$364.30 M(+44.6%)
$143.19 M(+39.1%)
$364.30 M(+20.8%)
Sep 2020
-
$102.91 M(+52.6%)
$301.46 M(+11.1%)
Jun 2020
-
$67.44 M(+32.8%)
$271.36 M(+9.6%)
Mar 2020
-
$50.77 M(-36.8%)
$247.66 M(-1.7%)
Dec 2019
$252.02 M(+11.3%)
$80.35 M(+10.4%)
$252.02 M(+8.9%)
Sep 2019
-
$72.81 M(+66.5%)
$231.34 M(+5.7%)
Jun 2019
-
$43.73 M(-20.7%)
$218.89 M(-4.4%)
Mar 2019
-
$55.13 M(-7.6%)
$228.88 M(+1.1%)
Dec 2018
$226.37 M(+83.5%)
$59.66 M(-1.2%)
$226.37 M(+65.4%)
Sep 2018
-
$60.37 M(+12.4%)
$136.86 M(+6.1%)
Jun 2018
-
$53.71 M(+2.0%)
$128.97 M(-0.2%)
Mar 2018
-
$52.63 M(-276.3%)
$129.21 M(+4.7%)
Dec 2017
$123.36 M(-20.3%)
-$29.85 M(-156.9%)
$123.36 M(-37.7%)
Sep 2017
-
$52.47 M(-2.7%)
$197.88 M(+8.0%)
Jun 2017
-
$53.95 M(+15.3%)
$183.15 M(+11.4%)
Mar 2017
-
$46.78 M(+4.7%)
$164.40 M(+6.2%)
Dec 2016
$154.76 M(+3.7%)
$44.68 M(+18.4%)
$154.76 M(+9.0%)
Sep 2016
-
$37.73 M(+7.2%)
$141.97 M(+0.3%)
Jun 2016
-
$35.21 M(-5.2%)
$141.61 M(-8.6%)
Mar 2016
-
$37.14 M(+16.5%)
$154.91 M(+3.8%)
Dec 2015
$149.31 M(+17.8%)
$31.88 M(-14.7%)
$149.31 M(+3.3%)
Sep 2015
-
$37.38 M(-22.9%)
$144.59 M(+3.8%)
Jun 2015
-
$48.51 M(+53.8%)
$139.25 M(+10.5%)
Mar 2015
-
$31.54 M(+16.1%)
$126.01 M(-0.5%)
Dec 2014
$126.70 M(+23.2%)
$27.17 M(-15.2%)
$126.70 M(+6.8%)
Sep 2014
-
$32.04 M(-9.2%)
$118.63 M(+1.0%)
Jun 2014
-
$35.26 M(+9.4%)
$117.46 M(+7.3%)
Mar 2014
-
$32.23 M(+68.8%)
$109.48 M(+6.5%)
Dec 2013
$102.83 M(+5.7%)
$19.10 M(-38.1%)
$102.83 M(+0.7%)
Sep 2013
-
$30.87 M(+13.1%)
$102.14 M(+9.5%)
Jun 2013
-
$27.28 M(+6.7%)
$93.25 M(-3.3%)
Mar 2013
-
$25.58 M(+38.9%)
$96.43 M(-0.9%)
Dec 2012
$97.30 M
$18.42 M(-16.2%)
$97.30 M(-8.2%)
Sep 2012
-
$21.97 M(-27.9%)
$105.99 M(+3.1%)
Jun 2012
-
$30.47 M(+15.2%)
$102.82 M(-1.8%)
DateAnnualQuarterlyTTM
Mar 2012
-
$26.44 M(-2.5%)
$104.67 M(-4.5%)
Dec 2011
$109.57 M(-132.5%)
$27.11 M(+44.2%)
$109.57 M(-142.0%)
Sep 2011
-
$18.80 M(-41.8%)
-$261.11 M(-14.3%)
Jun 2011
-
$32.32 M(+3.1%)
-$304.85 M(-5.5%)
Mar 2011
-
$31.34 M(-109.1%)
-$322.72 M(-4.1%)
Dec 2010
-$336.67 M(-394.2%)
-$343.56 M(+1277.5%)
-$336.67 M(-1476.2%)
Sep 2010
-
-$24.94 M(-272.6%)
$24.46 M(-71.8%)
Jun 2010
-
$14.45 M(-16.8%)
$86.72 M(-18.5%)
Mar 2010
-
$17.38 M(-1.1%)
$106.42 M(-7.0%)
Dec 2009
$114.44 M(-121.9%)
$17.57 M(-52.9%)
$114.44 M(-120.3%)
Sep 2009
-
$37.31 M(+9.2%)
-$563.66 M(+1.5%)
Jun 2009
-
$34.15 M(+34.4%)
-$555.49 M(+2.8%)
Mar 2009
-
$25.41 M(-103.8%)
-$540.58 M(+3.6%)
Dec 2008
-$521.84 M(-438.0%)
-$660.54 M(-1552.1%)
-$521.84 M(-397.2%)
Sep 2008
-
$45.49 M(-7.3%)
$175.60 M(+1.6%)
Jun 2008
-
$49.07 M(+11.2%)
$172.89 M(+6.9%)
Mar 2008
-
$44.14 M(+19.6%)
$161.78 M(+4.8%)
Dec 2007
$154.41 M(-376.8%)
$36.91 M(-13.7%)
$154.41 M(+1.1%)
Sep 2007
-
$42.78 M(+12.7%)
$152.69 M(+63.6%)
Jun 2007
-
$37.96 M(+3.2%)
$93.30 M(+15.1%)
Mar 2007
-
$36.76 M(+4.5%)
$81.09 M(-245.4%)
Dec 2006
-$55.78 M(-139.3%)
$35.19 M(-311.9%)
-$55.78 M(+37.6%)
Sep 2006
-
-$16.61 M(-164.5%)
-$40.55 M(-599.1%)
Jun 2006
-
$25.75 M(-125.7%)
$8.13 M(-42.9%)
Mar 2006
-
-$100.11 M(-298.6%)
$14.24 M(-90.0%)
Dec 2005
$142.00 M(+58.1%)
$50.42 M(+57.2%)
$142.00 M(+27.2%)
Sep 2005
-
$32.07 M(+0.7%)
$111.66 M(+5.9%)
Jun 2005
-
$31.86 M(+15.2%)
$105.41 M(+5.6%)
Mar 2005
-
$27.65 M(+37.7%)
$99.85 M(+11.2%)
Dec 2004
$89.79 M(+12.0%)
$20.08 M(-22.2%)
$89.79 M(-0.6%)
Sep 2004
-
$25.82 M(-1.8%)
$90.36 M(+7.4%)
Jun 2004
-
$26.30 M(+49.5%)
$84.13 M(+7.3%)
Mar 2004
-
$17.59 M(-14.8%)
$78.39 M(-2.2%)
Dec 2003
$80.15 M(+59.9%)
$20.64 M(+5.4%)
$80.15 M(+4.1%)
Sep 2003
-
$19.59 M(-4.7%)
$77.01 M(+1.4%)
Jun 2003
-
$20.56 M(+6.2%)
$75.95 M(+5.9%)
Mar 2003
-
$19.35 M(+10.6%)
$71.72 M(+43.1%)
Dec 2002
$50.13 M(+41.6%)
$17.50 M(-5.5%)
$50.13 M(+20.7%)
Sep 2002
-
$18.53 M(+13.5%)
$41.54 M(+23.9%)
Jun 2002
-
$16.33 M(-831.5%)
$33.53 M(+27.9%)
Mar 2002
-
-$2.23 M(-125.0%)
$26.22 M(-25.9%)
Dec 2001
$35.41 M(-415.5%)
$8.92 M(-15.2%)
$35.41 M(+14.5%)
Sep 2001
-
$10.52 M(+16.7%)
$30.92 M(-899.9%)
Jun 2001
-
$9.02 M(+29.7%)
-$3.87 M(-21.3%)
Mar 2001
-
$6.95 M(+57.0%)
-$4.91 M(-56.3%)
Dec 2000
-$11.22 M(-165.5%)
$4.43 M(-118.3%)
-$11.22 M(-28.3%)
Sep 2000
-
-$24.26 M(-404.3%)
-$15.65 M(-281.8%)
Jun 2000
-
$7.97 M(+1153.8%)
$8.61 M(+1253.8%)
Mar 2000
-
$636.00 K
$636.00 K
Dec 1999
$17.12 M(-26.8%)
-
-
Dec 1998
$23.38 M
-
-

FAQ

  • What is Charles River Laboratories International annual net profit?
  • What is the all time high annual net income for Charles River Laboratories International?
  • What is Charles River Laboratories International annual net income year-on-year change?
  • What is Charles River Laboratories International quarterly net profit?
  • What is the all time high quarterly net income for Charles River Laboratories International?
  • What is Charles River Laboratories International quarterly net income year-on-year change?
  • What is Charles River Laboratories International TTM net profit?
  • What is the all time high TTM net income for Charles River Laboratories International?
  • What is Charles River Laboratories International TTM net income year-on-year change?

What is Charles River Laboratories International annual net profit?

The current annual net income of CRL is $22.20 M

What is the all time high annual net income for Charles River Laboratories International?

Charles River Laboratories International all-time high annual net profit is $486.23 M

What is Charles River Laboratories International annual net income year-on-year change?

Over the past year, CRL annual net profit has changed by -$452.42 M (-95.32%)

What is Charles River Laboratories International quarterly net profit?

The current quarterly net income of CRL is -$213.41 M

What is the all time high quarterly net income for Charles River Laboratories International?

Charles River Laboratories International all-time high quarterly net profit is $187.41 M

What is Charles River Laboratories International quarterly net income year-on-year change?

Over the past year, CRL quarterly net profit has changed by -$307.19 M (-327.57%)

What is Charles River Laboratories International TTM net profit?

The current TTM net income of CRL is $22.20 M

What is the all time high TTM net income for Charles River Laboratories International?

Charles River Laboratories International all-time high TTM net profit is $496.33 M

What is Charles River Laboratories International TTM net income year-on-year change?

Over the past year, CRL TTM net profit has changed by -$418.61 M (-94.96%)